首页> 外文期刊>Journal of Molecular Biology >Cysteine-Independent Inhibition of Alzheimer's Disease-like Paired Helical Filament Assembly by Leuco-Methylthioninium (LMT)
【24h】

Cysteine-Independent Inhibition of Alzheimer's Disease-like Paired Helical Filament Assembly by Leuco-Methylthioninium (LMT)

机译:用甲基甲基氨基尼(LMT)的半胱氨酸抑制阿尔茨海默氏症的疾病状纤维丝组件

获取原文
获取原文并翻译 | 示例
           

摘要

Alzheimer's disease is a tauopathy characterized by pathological fibrillization of tau protein to form the paired helical filaments (PHFs), which constitute neurofibrillary tangles. The methylthioninium (MT) moiety reverses the proteolytic stability of the PHF core and is in clinical development for treatment of Alzheimer's disease in a stable reduced form as leuco-MT. It has been hypothesized that MT actsviaoxidation of cysteine residues, which is incompatible with activity in the predominantly reducing environment of living cells. We have shown recently that the PHF-core tau unit assembles spontaneouslyin vitroto form PHF-like filaments. Here we describe studies using circular dichroism, SDS-PAGE, transmission electron microscopy and site-directed mutagenesis to elucidate the mechanism of action of the MT moiety. We show that MT inhibitory activity is optimal in reducing conditions, that the active moiety is the reduced leuco-MT form of the molecule and that its mechanism of action is cysteine independent.
机译:阿尔茨海默病是一种特征,其特征是Tau蛋白的病理原纤维化,形成成对的螺旋丝细丝(PHF),构成神经原纤维缠结。甲基硫氨基鎓(MT)部分逆转了PHF核心的蛋白水解稳定性,并且在临床开发中以稳定的降低形式治疗阿尔茨海默病,为Leuco-mt。已经假设了半胱氨酸残基的MT Actsvia氧化,其与主要减少活细胞环境中的活性不相容。我们最近显示了PHF-Core Tau单位组装自来组织vitroto形式的pHF样细丝。在这里,我们描述了使用圆形二色性,SDS-PAGE,透射电子显微镜和定向诱变的研究,以阐明MT部分的作用机制。我们表明,在还原条件下,MT抑制活性是最佳的,所以活性部分是分子的降低的Leuco-Mt形式,并且其作用机制是半胱氨酸的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号